W2O Group has hired former client David Walsey as managing director of its BrewLife unit to lead its new outpost in San Diego.
He has more than 15 years of biopharma communications expertise and spent another ten as an attorney in private practice.
Walsey joins W2O frrm Optimer Pharmaceuticals, where he was VP-corporate communications/IR.
Prior to Optimer, which was acquired by Cubist Pharmaceuticals, he handled financial communications duties at Arena and Sarepta, which is now AVI Pharma.
Launched in 2013, Brewlife is the integrated brand communications arm of W2O, O'Dwyer's No. 4 ranked firm with $75M in 2013 fee income.
Edelman handles Viking Holdings, the river and ocean luxury cruise line that plans to raise $1B via an IPO priced in the $21 to $25 per share range.
Teneo is handling the initial public offering of CVC Capital Partners, one of Europe’s largest private equity firms with nearly $200B in assets under management.
Brunswick Group represents Endeavor Group Holdings as it agrees to go private via its acquisition by Silver Lake technology investment firm, which is handled by Edelman Smithfield.
Tod Donhauser, a nine-year veteran of Edelman, has joined H/Advisors Abernathy as managing director and head of its San Francisco office.
Intelligent Group Ltd, a Hong Kong-based financial PR firm, has priced its initial public offering of 1.9M shares at $4, which is the low end of the $4 to $5 range.
Have a comment? Send it to 
No comments have been submitted for this story yet.